328 related articles for article (PubMed ID: 7909498)
1. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
[TBL] [Abstract][Full Text] [Related]
2. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
[TBL] [Abstract][Full Text] [Related]
3. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
[TBL] [Abstract][Full Text] [Related]
4. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
5. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
[TBL] [Abstract][Full Text] [Related]
6. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
[TBL] [Abstract][Full Text] [Related]
7. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
[TBL] [Abstract][Full Text] [Related]
8. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor.
Blue ML; Daley JF; Levine H; Branton KR; Schlossman SF
J Immunol; 1989 Jan; 142(2):374-80. PubMed ID: 2783435
[TBL] [Abstract][Full Text] [Related]
10. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
Koulova L; Yang SY; Dupont B
J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
[TBL] [Abstract][Full Text] [Related]
11. An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites.
Kozarsky KF; Tsai C; Bott CM; Allada G; Li LL; Fox DA
Cell Immunol; 1993 Sep; 150(2):235-46. PubMed ID: 8103706
[TBL] [Abstract][Full Text] [Related]
12. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.
Subramanyam M; Gutheil WG; Bachovchin WW; Huber BT
J Immunol; 1993 Mar; 150(6):2544-53. PubMed ID: 8095514
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
Nunes J; Bagnasco M; Lopez M; Olive D; Mawas C
J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
[TBL] [Abstract][Full Text] [Related]
15. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
[TBL] [Abstract][Full Text] [Related]
16. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro.
Bloemena E; Van Oers RH; Weinreich S; Stilma-Meinesz AP; Schellekens PT; Van Lier RA
Eur J Immunol; 1989 May; 19(5):943-6. PubMed ID: 2567675
[TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation.
Le Deist F; Thoenes G; Corado J; Lisowska-Grospierre B; Fischer A
Eur J Immunol; 1991 Jul; 21(7):1641-7. PubMed ID: 1676369
[TBL] [Abstract][Full Text] [Related]
18. Induction of negative signal through CD2 during antigen-specific T cell activation.
Ohno H; Nakamura T; Yagita H; Okumura K; Taniguchi M; Saito T
J Immunol; 1991 Oct; 147(7):2100-6. PubMed ID: 1680913
[TBL] [Abstract][Full Text] [Related]
19. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
